A Preclinical Population Pharmacokinetic Model for Anti‐CD20/CD3 T‐Cell‐Dependent Bispecific Antibodies

Por Ferl, Gregory Z., Reyes, Arthur, Sun, Liping L., Cheu, Melissa, Oldendorp, Amy, Ramanujan, Saroja, Stefanich, Eric G.
Publicado no Clin Transl Sci (2018)

Effect of antigen binding affinity and effector function on the pharmacokinetics and pharmacodynamics of anti-IgE monoclonal antibodies

Por Mortensen, Deborah L., Prabhu, Saileta, Stefanich, Eric G., Kadkhodayan-Fischer, Saloumeh, Gelzleichter, Thomas R., Baker, Dana, Jiang, Jenny, Wallace, Kristin, Iyer, Suhasini, Fielder, Paul J., Putnam, Wendy S.
Publicado em 2012

Nonclinical safety assessment of a human interleukin‐22FC IG fusion protein demonstrates in vitro to in vivo and cross‐species translatability

Por Lee, Donna W., Zhong, Shelly, Pai, Rama, Rae, Julie, Sukumaran, Siddharth, Stefanich, Eric G., Lutman, Jeff, Doudement, Estelle, Wang, Xiaoting, Harder, Brandon, Lekkerkerker, Annemarie, Herman, Ann, Ouyang, Wenjun, Danilenko, Dimitry M.
Publicado no Pharmacol Res Perspect (2018)